Correlation Between Jindal Saw and Krebs Biochemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jindal Saw and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jindal Saw and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jindal Saw Limited and Krebs Biochemicals and, you can compare the effects of market volatilities on Jindal Saw and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jindal Saw with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jindal Saw and Krebs Biochemicals.

Diversification Opportunities for Jindal Saw and Krebs Biochemicals

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Jindal and Krebs is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Jindal Saw Limited and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and Jindal Saw is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jindal Saw Limited are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of Jindal Saw i.e., Jindal Saw and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between Jindal Saw and Krebs Biochemicals

Assuming the 90 days trading horizon Jindal Saw is expected to generate 37.9 times less return on investment than Krebs Biochemicals. But when comparing it to its historical volatility, Jindal Saw Limited is 3.2 times less risky than Krebs Biochemicals. It trades about 0.02 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  8,437  in Krebs Biochemicals and on September 4, 2024 and sell it today you would earn a total of  2,537  from holding Krebs Biochemicals and or generate 30.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Jindal Saw Limited  vs.  Krebs Biochemicals and

 Performance 
       Timeline  
Jindal Saw Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Jindal Saw Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Krebs Biochemicals and 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Jindal Saw and Krebs Biochemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jindal Saw and Krebs Biochemicals

The main advantage of trading using opposite Jindal Saw and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jindal Saw position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.
The idea behind Jindal Saw Limited and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data